NUVL Competitors & Alternatives
Compare Nuvalent Inc with similar stocks in the same industry
Biotechnology
NUVL
Main Stock$102.30
Tradestie Score
51
Market Cap
$5.95B
Analyst Upside
+38.9%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TECH
Bio-Techne Corp.
|
$43.30
|
$9.33B | 63.9 | 51 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$56.37
|
$8.88B | 166.6 | 56 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$67.12
|
$8.77B | 24.3 | 61 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$145.66
|
$8.57B | - | 61 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$14.55
|
$8.53B | - | 40 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$228.77
|
$8.30B | 1925.4 | 64 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$75.85
|
$6.68B | - | 62 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$90.52
|
$6.64B | - | 58 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$114.53
|
$6.38B | - | 46 | Compare |
More NUVL Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry